1-5 of 5
Takao Hamakubo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3293: CADM1 is a serum marker for small-cell lung cancer associated with poor prognosis and metastasis

Free
Takeshi Ito, Toko Funaki, Hiroko Iwanari, Goh Tanaka, Takahide Nagase, Takao Hamakubo, Yoshinori Murakami
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3293.
https://doi.org/10.1158/1538-7445.AM2023-3293
Published: 04 April 2023
View article titled, Abstract 3293: CADM1 is a serum marker for small-cell lung cancer associated with poor prognosis and metastasis
Journal Articles

Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas

Free
Jian Pan, Tiago C. Silva, Nicole Gull, Qian Yang, Jasmine T. Plummer, Stephanie Chen, Kenji Daigo, Takao Hamakubo, Sigal Gery, Ling-Wen Ding, Yan-Yi Jiang, Shaoyan Hu, Li-Yan Xu, En-Min Li, Yanbing Ding, Samuel J. Klempner, Simon A. Gayther, Benjamin P. Berman, H. Phillip Koeffler, De-Chen Lin
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (13): 2722–2736.
https://doi.org/10.1158/0008-5472.CAN-20-0390
Published: 02 July 2020
View article titled, Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas
Open the PDF for Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas in another window
Includes: Supplementary data
Journal Articles

Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer

Free
Takahiro Ishiguro, Yasuko Kinoshita, Masamichi Sugimoto, Yoko Miyazaki, Atsuhiko Kato, Kiyotaka Nakano, Hirotake Takai, Hiroyuki Tsunoda, Izumi Sugo, Iwao Ohizumi, Hiroyuki Aburatani, Takao Hamakubo, Tatsuhiko Kodama, Masayuki Tsuchiya, Hisafumi Yamada Okabe
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2426.
https://doi.org/10.1158/1538-7445.AM10-2426
Published: 15 April 2010
View article titled, Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer
Journal Articles

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Free
Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita, Yoko Miyazaki, Kiyotaka Nakano, Hiroyuki Tsunoda, Izumi Sugo, Iwao Ohizumi, Hiroyuki Aburatani, Takao Hamakubo, Tatsuhiko Kodama, Masayuki Tsuchiya, Hisafumi Yamada-Okabe
Journal: Cancer Research
Cancer Res (2008) 68 (23): 9832–9838.
https://doi.org/10.1158/0008-5472.CAN-08-1973
Published: 01 December 2008
View article titled, Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Open the PDF for Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer in another window
Journal Articles

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Free
Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe, Yutaka Midorikawa, Shogo Yamamoto, Sigeo Ihara, Susumu Tokita, Hiroko Iwanari, Yukio Ito, Kiyotaka Nakano, Jun-ichi Nezu, Hiroyuki Tsunoda, Takeshi Yoshino, Iwao Ohizumi, Masayuki Tsuchiya, Shin Ohnishi, Masatoshi Makuuchi, Takao Hamakubo, Tatsuhiko Kodama, Hiroyuki Aburatani
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2418–2423.
https://doi.org/10.1158/0008-5472.CAN-03-2191
Published: 01 April 2004
View article titled, Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma
Open the PDF for Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma in another window